Drugs

Alkeran

Generic Name: Melphalan
Product Name: Alkeran

Indication of Alkeran:

Alkeran is used in the treatment of:

^ top

Action of Alkeran:

Melphalan acts by preventing replication of tumour cells by forming cross-linkages between DNA strands.

^ top

Dose advice of Alkeran:

Specialist protocols should be consulted.The following doses are recommended initial doses. Further courses and doses depend on the individual patient's response and side effects.Multiple myeloma:
  • 150 micrograms/kg orally given in divided doses daily for 4-7 days.
  • Melphalan is given in combination with prednisolone 40-60 mg daily for 4 days.
High dose therapy:
  • 100-200 mg/m 2 intravenously daily.
  • Melphalan is given in combination with autologous hemopoietic stem cell support.
Renal impairment:
  • In patients with moderate to severe renal impairment intravenous doses should be halved and reduction of oral doses should be considered.
  • High dose therapy should not be used in patients with moderate to severe renal impairment.
Pregnancy:
  • Melphalan can cause spontaneous abortion, foetal loss and birth defects and should be avoided during pregnancy. It should also be avoided during breastfeeding.

^ top

Schedule of Alkeran:

S4

^ top

Common side effects of Alkeran:

  • Bone marrow suppression, which can result in low white cell and platelet counts, which can cause an increased susceptibility to infections and bleeding respectively.
  • Nausea.
  • Vomiting.
  • Diarrhoea.
  • Mouth ulcers (common at high doses).
  • Hair loss (very common at high doses).
  • Amenorrhoea (absence of menstruation in women).

^ top

Uncommon side effects of Alkeran:

  • Temporary or permanent infertility in both women and men.
  • Hypersensitivity, allergy or anaphylaxis.
  • Liver disease ranging from abnormal blood tests to hepatitis (inflammation of the liver) and jaundice (yellowing of the skin and white parts of the eyes due to increased bilirubin in the blood).
  • Temporarily raised blood urea in patients with multiple myeloma with damaged kidneys (seen on a blood test).
  • Interstitial pneumonitis (inflammation of the tissues in the lung).
  • Pulmonary fibrosis (chronic scarring of the lung tissue).
  • Melphalan may increase the risk of leukaemia and secondary malignancies (cancers) developing.
  • Overdose may result in severe nausea, vomiting, diarrhoea, damage to the gut lining, inflammation of the tissues in the gut and mouth, bleeding, abnormal blood clotting, decreased consciousness, convulsions or paralysis.

^ top

Diseases treated by Alkeran:


For further information talk to your doctor.


Website Tools

Sign up for free newsletter Sign up for free newsletters
News RSS feeds Subscribe to RSS feeds
Discuss on Forum Discuss on Forum

 

Article Tools

Email this article to a friend Email this article to a friend
Share on Twitter Share on Twitter
Share on Facebook Share on Facebook
Share on StumbleUpon Share on StumbleUpon
Print this article Print this article
Bookmark this page Bookmark this page (press Ctrl+D)

Article Dates:

calendar icon Created: 22/7/2003 calendar icon Modified: 5/9/2007

Current Sponsors
Proudly brought to you by
Proudly brought to you by
Sponsors Logos
Accreditation and Awards
Accreditations and Awards
Our site has been approved by the HealthInsite Editorial Board to be a HealthInsite information partner site PANDORA is a digital archive dedicated to the preservation of and long term access to Australian online electronic publications of national significance No. 1 Website in the Hitwise Top 10 Website Award in recognition of outstanding performance WAITTA Winner 2008 Online 2005 Finalist in the Secrets of Australian IT Innovation Awards Australian Prime Minister's awards for excellence in community business partnerships 2004
2004 Finalist in the Secrets of Australian IT Innovation Awards
Current Sponsors

Virtual Medical Centre

Australia’s leading source for trustworthy medical information written by health professionals.

Please be aware that we do not give advice on your individual medical condition,
if you want advice please see your treating physician.

Information on this site must be discussed with your treating doctor.

Virtual Medical Centre © 2002 - 2010 | Privacy Policy Last updated 3 Sep 2010

News RSS feedsRSS News feed

For Banner Advertising
MediaSmart

Website and videos by
Titan Interactive, Website and Web Design Perth Australia

^ Back to Top